Growing evidence indicates that adipose tissue inflammation is an important mechanism whereby obesity promotes cancer risk and progression. Since IL-32 is an important inflammatory and remodeling factor in obesity and is also related to colon cancer (CC) development, the aim of this study was to explore whether IL-32 could function as an inflammatory factor in human obesity-associated CC promoting a microenvironment favorable for tumor growth. Samples obtained from 84 subjects [27 lean (LN) and 57 obese (OB)] were used in the study. Enrolled subjects were further subclassified according to the established diagnostic protocol for CC (49 without CC and 35 with CC). We show, for the first time, that obesity ( = 0.009) and CC ( = 0.026) increase circulating concentrations of IL-32α. Consistently, we further showed that gene ( < 0.05) and protein ( < 0.01) expression levels of IL-32α were upregulated in VAT from obese patients with CC. Additionally, we revealed that expression levels are enhanced by hypoxia and inflammation-related factors in HT-29 CC cells as well as that IL-32α is involved in the upregulation of inflammation (, and ) and extracellular matrix (ECM) remodeling ( and ) genes in HT-29 cancer cells. Additionally, we also demonstrate that the adipocyte-conditioned medium obtained from obese patients stimulates ( < 0.05) the expression of in human CC cells. These findings provide evidence of the potential involvement of IL-32 in the development of obesity-associated CC as a pro-inflammatory and ECM remodeling cytokine.
Background: intraductal papillary mucinous neoplasm (IPMN) shows a series of lesions which evolve from benign lesions -adenoma-to invasive carcinoma.Aim: to analyze the clinical and pathological results of 15 patients diagnosed of IPMN, and surgically treated according to the guidelines of International Consensus Conference.Material and methods: a retrospective analysis of 15 patients surgically treated between March 1993 and September 2009, according to the International Consensus recommendation. Demographic, diagnostic tools, surgical report, pathologic database and actuarial survival were analyzed with a follow-up from one and a half month through nine years.Results: 6 patients underwent pancreaticoduodenectomies, 4 total pancreatectomies, 2 body or central pancreatectomies, 2 partial pancreatectomies (enucleation) and 1 distal pancreatectomy. A morbidity of 46 and 0% hospital mortality were assessed, with a median length hospital stay of 10 days. In five cases, the IPMN was combined type (both main and branch pancreatic ducts involved) in four main duct-type and branch duct-type in the another six as well. Several atypia (IPMN carcinoma in situ) was observed in 2 patients and invasive carcinoma with negative lymph nodes was identified in 3 patients. A patient without invasive carcinoma died at 66 months of follow-up for pancreas adenocarcinoma. The actuarial survival up to recurrence or death was 105,133 months with a range of follow-up from 1 month and a half until 9 years.Conclusions: IPMN main duct or mixed type warrants complete resection due to its incidence of invasive carcinoma or precursor lesions of malignancy as well. Due to its multifocal pattern, patients should be followed in long-term surveillance. The management of asymptomatic IPMN type branch less than 3 cm is controversial. RESUMENIntroducción: la neoplasia papilar mucinosa intraductal (NPMI) del páncreas comprende una serie de lesiones que evolucionan desde lesiones benignas (adenoma) hasta carcinoma ductal invasivo.Objetivo: analizar los resultados clínicos y patológicos de 15 pacientes diagnosticados de NPMI e intervenidos según las recomendaciones de conferencia de consenso.Material y métodos: análisis retrospectivo de 15 pacientes con NPMI, intervenidos entre marzo de 1993 y septiembre de 2009; según pautas de conferencias de consenso internacionales. Se recogieron datos demográficos, pruebas diagnósticas, tipo de intervención, histopatología y supervivencia actuarial con un seguimiento entre mes y medio y nueve años.Resultados: se realizaron 6 duodenopancreatectomías cefálicas, 4 pancreatectomías totales, 2 pancreatectomías centrales, 2 pancreatectomías parciales y una pancreatectomía distal. Se registró una morbilidad del 40%, sin mortalidad operatoria, con una estancia media de 10 días. En 5 casos la NPMI fue de tipo mixto, en 4 afectaba al conducto pancreático y en los 6 restantes a ramas accesorias. Dos pacientes presentaron carcinoma in situ y 3 carcinoma invasivo con ganglios negativos. Un paciente, sin carcinoma invasivo, fallec...
Production of climatic and bioclimatic maps by Universal Kriging with external drift: theory and examplesfor Italy. In this paper GIS-based maps of climatic and bioclimatic data for Italy have been obtained by inter polating values observed at measurement stations. Long-term (1961Long-term ( -1990 average monthly data were obtai ned from weather stations measuring precipitation (1102 sites) and temperature (321 sites). We analysed twelve climatic variables (temperature and precipitation) and nine bioclimatic indexes. Terrain variables and geographical location have been used as predictors of climate variables: longitude, latitude, elevation, aspect, slope, continentality and estimated solar radiation. Universal kriging (i.e., simple kriging with trend function defined on the basis of a set of covariates), which is optimal (i.e., BLUP, best linear unbiased predictor) if spa tial association is present, has been used as spatial interpolator. Based on the root mean square errors from cross-validation tests, we ranked the best search radius for each variable data set. A 15 km search radius has been demonstrated to be the best one to model precipitation variables and precipitation-based bioclimatic in dexes, while temperature variables were modelled using a 30 km radius.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.